Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
55.17
-1.69 (-2.96%)
At close: Sep 15, 2026, 4:00 PM EDT
55.00
-0.16 (-0.30%)
After-hours: Sep 15, 2026, 5:40 PM EDT
Spruce Biosciences Employees
Spruce Biosciences had 22 employees as of June 30, 2026. The number of employees increased by 13 or 144.44% compared to the same quarter last year.
Employees
22
Change
13
Growth
144.44%
Revenue / Employee
n/a
Profits / Employee
-$2,334,227
Market Cap
158.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 22 | 13 | 144.44% |
| Mar 31, 2026 | 14 | -6 | -30.00% |
| Dec 31, 2025 | 8 | -13 | -61.90% |
| Sep 30, 2025 | 9 | -13 | -59.09% |
| Jun 30, 2025 | 9 | -13 | -59.09% |
| Mar 31, 2025 | 20 | -2 | -9.09% |
| Dec 31, 2024 | 21 | -8 | -27.59% |
| Sep 30, 2024 | 22 | -9 | -29.03% |
| Jun 30, 2024 | 22 | -10 | -31.25% |
| Mar 31, 2024 | 22 | -8 | -26.67% |
| Dec 31, 2023 | 29 | 2 | 7.41% |
| Sep 30, 2023 | 31 | 9 | 40.91% |
| Jun 30, 2023 | 32 | 15 | 88.24% |
| Mar 31, 2023 | 30 | 14 | 87.50% |
| Dec 31, 2022 | 27 | 12 | 80.00% |
| Sep 30, 2022 | 22 | 3 | 15.79% |
| Jun 30, 2022 | 17 | -4 | -19.05% |
| Mar 31, 2022 | 16 | -3 | -15.79% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Codexis | 146 |
| Molecular Partners AG | 134 |
| Immunic | 100 |
| Tenaya Therapeutics | 70 |
| Corbus Pharmaceuticals Holdings | 36 |
| Jyong Biotech | 27 |
| Unicycive Therapeutics | 22 |
SPRB News
- 4 hours ago - Spruce Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 7 days ago - Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 20 days ago - Spruce Biosciences announces launch of MPS3BStudy.com - TheFly
- 20 days ago - Spruce Biosciences Announces Launch of MPS3BStudy.com - Business Wire
- 22 days ago - Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026 - Business Wire
- 4 weeks ago - Spruce Biosciences price target lowered to $104 from $123 at Guggenheim - TheFly
- 4 weeks ago - Cure Sanfilippo, National MPS agree to make $5.5M investment in Spruce - TheFly
- 4 weeks ago - Spruce Biosciences reports Q2 EPS ($6.68), consensus ($5.93) - TheFly